SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
10-Dec-04 6:05 PM View: | Singh Sharat Chief Technology Officer | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 70,003 | -- | -- | (100%) 70.0K to 0 | |
14-Dec-04 6:38 PM View: | Tang Oscar | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 573,300 | -- | -- | (92%) 623.3K to 50.0K | |
14-Dec-04 6:38 PM View: | Tang Capital Partners Lp 10% Owner | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
10-Dec-04 6:12 PM View: | Baruch Thomas R Director | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 170,302 | -- | -- | (100%) 170.3K to 0 | |
10-Dec-04 6:10 PM View: | Klopack Thomas G Chief Executive Officer Director | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 15,000 | -- | -- | (100%) 15.0K to 0 | |
14-Dec-04 6:38 PM View: | Tang Oscar | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 50,000 | -- | -- | (100%) 50.0K to 0 | |
10-Dec-04 6:06 PM View: | Merriweather Alfred G VP Finance, CFO | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 5,908 | -- | -- | (100%) 5.91K to 0 | |
10-Dec-04 6:11 PM View: | Dunn Michael John Chief Business Officer | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 6,436 | -- | -- | (100%) 6.44K to 0 | |
14-Dec-04 6:38 PM View: | Tang Capital Partners Lp 10% Owner | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 3,524,100 | -- | -- | (100%) 3.53M to 5.0K | |
10-Dec-04 6:12 PM View: | Baruch Thomas R Director | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 66,135 | -- | -- | (28%) 236.44K to 170.3K | |
07-Jan-04 10:00 PM View: | Baruch Thomas R Director | Aclara Biosciences Inc (ACLA) | 05-Jan-04 | Acquisition (other) | 16,040 | -- | -- | 2% 729.72K to 745.76K | |
07-Jan-04 10:00 PM View: | Baruch Thomas R Director | Aclara Biosciences Inc (ACLA) | 05-Jan-04 | Disposition (other) | 341,323 | -- | -- | (46%) 745.76K to 404.43K | |
04-Dec-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 03-Dec-03 | Sale (Planned) | 9,359 | $3.54 | $33,113.30 | (3%) 344.8K to 335.44K | |
03-Dec-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 02-Dec-03 | Sale (Planned) | 641 | $3.53 | $2,262.73 | (< 1%) 345.44K to 344.8K | |
01-Dec-03 10:00 PM View: | MacEvicz Stephen VP Intellectual Property | Aclara Biosciences Inc (ACLA) | 26-Nov-03 | Option Sale | 10,000 | $3.19 | $31,940.00 | (3%) 300.0K to 290.0K | |
01-Dec-03 10:00 PM View: | MacEvicz Stephen VP Intellectual Property | Aclara Biosciences Inc (ACLA) | 26-Nov-03 | Option Exercise | 10,000 | $2.76 | $27,600.00 | 3% 290.0K to 300.0K | |
04-Nov-03 10:00 PM View: | Singh Sharat Vice President | Aclara Biosciences Inc (ACLA) | 03-Nov-03 | Grant | 5,000 | $2.07 | $10,370.00 | 8% 65.0K to 70.0K | |
04-Nov-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 03-Nov-03 | Sale (Planned) | 10,000 | $3.55 | $35,491.90 | (3%) 355.44K to 345.44K | |
03-Oct-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 02-Oct-03 | Sale (Planned) | 10,000 | $4.54 | $45,374.00 | (3%) 365.44K to 355.44K | |
02-Oct-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 01-Oct-03 | Sale (Planned) | 10,000 | $4.00 | $40,019.00 | (3%) 375.44K to 365.44K | |
03-Sep-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 02-Sep-03 | Sale (Planned) | 10,000 | $3.57 | $35,654.50 | (3%) 385.44K to 375.44K | |
27-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 27-Aug-03 | Sale | 2,000 | $3.57 | $7,132.00 | (< 1%) 387.44K to 385.44K | |
21-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 21-Aug-03 | Sale | 2,000 | $3.72 | $7,436.00 | (< 1%) 389.44K to 387.44K | |
19-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 18-Aug-03 | Sale | 4,000 | $3.54 | $14,146.00 | (1%) 393.44K to 389.44K | |
13-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 12-Aug-03 | Sale | 4,000 | $3.48 | $13,935.40 | (< 1%) 792.88K to 788.88K | |
12-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 11-Aug-03 | Sale | 2,000 | $3.39 | $6,780.10 | (< 1%) 399.44K to 397.44K | |
05-Aug-03 10:00 PM View: | Hooper Herbert H Director | Aclara Biosciences Inc (ACLA) | 04-Aug-03 | Sale | 5,200 | $3.81 | $19,815.00 | (1%) 404.64K to 399.44K |